Paisant, A.; Boursier, J.; Dabli, D.; Lebigot, J.; Oberti, F.; Michalak, S.; Vilgrain, V.; Aubé, C.
Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma. J. Clin. Med. 2022, 11, 4282.
https://doi.org/10.3390/jcm11154282
AMA Style
Paisant A, Boursier J, Dabli D, Lebigot J, Oberti F, Michalak S, Vilgrain V, Aubé C.
Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma. Journal of Clinical Medicine. 2022; 11(15):4282.
https://doi.org/10.3390/jcm11154282
Chicago/Turabian Style
Paisant, Anita, Jérôme Boursier, Djamel Dabli, Jérôme Lebigot, Frédéric Oberti, Sophie Michalak, Valérie Vilgrain, and Christophe Aubé.
2022. "Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma" Journal of Clinical Medicine 11, no. 15: 4282.
https://doi.org/10.3390/jcm11154282
APA Style
Paisant, A., Boursier, J., Dabli, D., Lebigot, J., Oberti, F., Michalak, S., Vilgrain, V., & Aubé, C.
(2022). Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma. Journal of Clinical Medicine, 11(15), 4282.
https://doi.org/10.3390/jcm11154282